These devices will be installed in the homes of individuals living alone. Since the equipped user must not be identified by the system among several cohabitants, these devices must not require the user to wear a device for identification, thus addressing various concerns: stigmatization, ergonomics, and the risk of forgetting to wear the device, rendering it ineffective. This lot is divided into items: Item 1.1: Device. The price submitted for this item must include both the cost of supplying the device and maintenance (as described in the SLA) for the entire duration of the framework agreement (i.e., 4 years), as well as related training. Item 1.2: Cost of the monthly data subscription. The bidder must guarantee optimal network coverage (e.g., M2M roaming). Item 1.3: Cost of installing the device at the user's home (in the Walloon Region). It is essential that no damage be caused during the installation. If any damage is found, the cost of repair and restoration to original condition will be borne by the successful bidder. Item 1.4: Cost for uninstalling the device at the beneficiary's home (in the Walloon Region). It is understood that no damage may occur during this process. If any damage is found, the cost of repair and restoration to original condition will be borne by the successful bidder. Item 1.5: Cost for installing a key box. This key box will be installed to facilitate emergency response in the event of a necessary alert and to prevent damage to the beneficiaries' homes. This is all the more important as the reliability of the system's AI and the resulting false positives remain a point of vigilance in the project. | In this case, the system must be able to distinguish between the equipped beneficiary (monitored, secured) and their cohabitant(s) in order to feed the AI and trigger alerts only for them. In addition, these systems must also allow for the equipping of several cohabitants by identifying and securing each one individually. If this requires...
Your competitors are watching the same crowded contracts everyone else is. Track live opportunities like this one worldwide, set deadline alerts, and win where they aren’t. Free for 14 days, no card.
Start Free| Issuing agency | Aide Digitale à Domicile |
|---|
| Country | Belgium |
|---|
| Category | Pharmaceuticals |
|---|
| CPV | 85300000 |
|---|
| Published | October 13, 2023 |
|---|
| Procurement stage | Active solicitation |
|---|
| Closed | Closing date not published |
|---|
| Status | Closed — no longer accepting responses |
|---|
| Official source | View original notice |
|---|
| Last verified | October 10, 2026 |
|---|
Source: Tenders Electronic Daily (TED), © European Union. Notice content reused under Commission Decision 2011/833/EU; editorial content licensed CC BY 4.0. GlobalGov is not affiliated with the European Union.
Belgium, Latvia, Germany, France, Romania, Denmark, Spain, Italy, Ireland, Luxembourg, Slovakia, Hungary, Malta, Netherlands, Greece, Austria, Slovenia, Estonia, Portugal – IT services: consulting, software development, Internet and support – Development, Implementation, Maintenance and Operation of financial IT Systems Belgium, Latvia, Germany, France, Romania, Denmark, Spain, Italy, Ireland, Luxembourg, Slovakia, Hungary, Malta, Netherlands, Greece, Austria, Slovenia, Estonia, Portugal – IT services: consulting, software development, Internet and support – Development, Implementation, Maintenance and Operation of financial IT Systems Belgium, Latvia, Germany, Spain, France, Poland, Sweden, Finland, Romania, Denmark, Italy, Ireland, Luxembourg, Slovakia, Portugal, Netherlands, Hungary, Malta, Greece, Austria, Slovenia, Estonia – Accounting and auditing services – Financial and accounting support Belgium, Latvia, Germany, Spain, France, Poland, Sweden, Finland, Romania, Denmark, Italy, Ireland, Luxembourg, Slovakia, Portugal, Netherlands, Hungary, Malta, Greece, Austria, Slovenia, Estonia – Accounting and auditing services – Financial and Accounting Support Belgium, Latvia, Germany, Sweden, Greece, Finland, Romania, Luxembourg, Netherlands, Austria, Spain – Television broadcast transmission services – Audiovisual coverage of current affairs and audiovisual production See every Belgium Pharmaceuticals opportunity your competition is missing. Free for 14 days.
Get real-time alerts, competitive intelligence, and deadline tracking for this and every market worldwide.
Start Free Trial — No Card RequiredFree 14-day trial · no card required
See who is already competing here →Used by capture teams who win by looking where the big players aren’t.
Get a free Belgium Pharmaceuticals intelligence report in your inbox
A personalized report on Belgium Pharmaceuticals opportunities, emailed in 5-10 minutes. One per month, no account needed.